#Endovascular Stent Graft Market Analysis
Explore tagged Tumblr posts
paul1-1 · 1 year ago
Text
0 notes
healthcareruhi · 11 months ago
Text
Vascular Guidewires Market Analysis, Share, Growth rate and Market Forecasts to 2030
The Global Vascular Guidewires Market was valued at US$ 981 Mn in 2022, estimated to reach US$ 1,791 Mn by 2030, with a CAGR of 7.69% from 2023-2030. A guidewire is a flexible wire that, in some circumstances, may also be a spring. It aids surgeons in the introduction and accurate positioning of a medical device, notably a prosthesis, within a patient's body. During an interventional procedure, the use of guidewires is crucial since they help a doctor and direct a medical instrument through the patient's anatomy. 
A guidewire completes the role of a guide towards the insertion of larger devices, such as a catheter, into the patient's body. The material majorly used in making guidewire is core steel with a covering applied over the core steel. The coating may be of hydrophilic or hydrophobic polymer. The vascular guidewires are used for the numerous surgical procedures such as angioplasty stents, angioplasty balloons, endovascular aneurysm repair stent grafts, hemodynamic flow alteration devices, and others.
Market Segmentation The scope of the Global Vascular Guidewires Market covers segmentation based on Application, Coating Type, End User, and Region. Based on Application, the market is segmented into Coronary Guidewires, Peripheral Guidewires, Urology Guidewires, and Neurovascular Guidewires. Based on Coating Type, the market is divided into Coated and Non-Coated. Based on End Users, the market is classified into Hospitals and Ambulatory Surgical Centers. Request A Free Sample@
Regional Analysis The Global Vascular Guidewires Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Key Players Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company (C.R. Bard), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical Inc., Olympus Corporation, and Terumo Corporation.
Key Questions Addressed by the Report • What are the Key Opportunities in Global Bonsai Market?   • What will be the growth rate from 2023 to 2030?   • Which segment/region will have the highest growth?   • What are the factors that will impact/drive the Market?   • What is the competitive Landscape in the Industry?
About Us:
QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers.
QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence.
QualiKet Research strive hard to simplify strategic decisions enabling you to make right choice. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition. Our experts provide deep insights which is not available publicly that enables you to take bold steps.
Contact Us:
     6060 N Central Expy #500 TX 75204, U.S.A
     +1 214 660 5449
     1201, City Avenue, Shankar Kalat Nagar,
     Wakad, Pune 411057, Maharashtra, India
     +91 9284752585
     Sharjah Media City , Al Messaned, Sharjah, UAE.
     +91 9284752585
0 notes
pranalipawarshinde · 1 year ago
Text
Vascular Grafts Market growth, business opportunities, share value, key insights and size estimation by 2031 | erumo Medical Corporation, and W. L. Gore & Associates, Inc
Global Vascular Grafts Market report from Global Insight Services is the single authoritative source of intelligence on Vascular Grafts Market . The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS21376
A vascular graft is a surgical procedure in which a section of a healthy blood vessel is removed from one area of the body and transplanted to another area to replace a damaged or diseased blood vessel. The most common type of vascular graft is an arterial graft, which is used to replace a damaged or diseased artery. Arterial grafts can be made from a variety of different materials, including synthetic materials, such as Dacron, or natural materials, such as veins or arteries from another part of the body. Vascular grafts are also used to create new blood vessels, such as when a bypass graft is used to create a new route around a blockage in an artery.
Key Trends
There are a few key trends in vascular graft technology.
One is the development of new materials that can be used for grafts. This includes things like using synthetic materials or using biodegradable materials.
Another trend is the development of new methods for making grafts. This includes using 3D printing or using nanotechnology.
Finally, there is a trend toward developing new methods for attaching grafts to the body. This includes using things like adhesive tape or staples.
Key Drivers
There are several key drivers of the vascular graft market.
The first is the aging population. As people age, they are more likely to develop diseases that require vascular surgery, such as atherosclerosis.
The second driver is the increasing prevalence of obesity and diabetes. These conditions increase the risk of developing vascular disease.
The third driver is the improving technology of vascular grafts. This has led to better outcomes for patients and increased demand for these products.
Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS21376
Restraints & Challenges
The key restraints and challenges in the vascular grafts market include the lack of availability of suitable donors, the high cost of the procedures, and the risk of complications associated with the procedures.
Market Segments
The Vascular Grafts Market is segmented by product, raw material, and end users. By product, the market is mainly categorized into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular aneurysm repair stent grafts are further subcategorized into abdominal aortic aneurysm and thoracic aortic aneurysm. By raw material, it is categorized in polyester, polytetrafluoroethylene, polyurethane, and biosynthetic. By end user, it is divided into hospitals and ambulatory surgical centers. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.
Key Players
The Vascular Grafts Market includes players such as  B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation, and W. L. Gore & Associates, Inc.
Buy Now – https://www.globalinsightservices.com/checkout/single_user/GIS21376
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
New Report Published by Global Insight Services –https://www.globalinsightservices.com/reports/hydrogen-projects-database/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: [email protected] Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/
0 notes
neha24blog · 1 year ago
Text
Peripheral Vascular Devices Market Segmented On The Basis Of Type, Region And Forecast 2030: Grand View Research Inc.
San Francisco, 6 July 2023: The Report Peripheral Vascular Devices Market Size, Share & Trends Analysis Report By Type (Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices), By Region, And Segment Forecasts, 2023 – 2030 The global peripheral vascular devices market size is expected to reach USD 11,574.4 million by 2030, to expand at…
Tumblr media
View On WordPress
0 notes
marketsizereports · 1 year ago
Text
Emerging Technologies and Innovations in the North America Aortic and Vascular Graft Procedures Market
The North America Aortic and Vascular Graft Procedures market has been witnessing significant advancements in technology and innovation. These emerging technologies are aimed at improving patient outcomes, reducing complications, and enhancing the overall efficacy of aortic and vascular graft procedures. Here are some notable innovations in this field:
Endovascular Aneurysm Repair (EVAR): EVAR is a minimally invasive procedure used to treat abdominal aortic aneurysms (AAAs). It involves the placement of a stent graft within the aorta to reinforce the weakened vessel walls and prevent aneurysm rupture. EVAR has gained popularity due to its reduced invasiveness, shorter recovery times, and lower mortality rates compared to open surgical repair.
Fenestrated and Branched Endovascular Aortic Repair (FEVAR and BEVAR): FEVAR and BEVAR are advanced techniques used to treat complex aortic aneurysms that involve the renal arteries or other branch vessels. These procedures utilize custom-made stent grafts with fenestrations or branches that align with the patient's specific anatomy, allowing for precise deployment and preservation of blood flow to vital organs.
Bioactive and Biodegradable Grafts: Bioactive grafts are designed to stimulate tissue regeneration and promote healing. They may incorporate growth factors or coatings that encourage the body's natural healing processes, leading to better integration of the graft and reduced risk of complications. Biodegradable grafts are gradually absorbed by the body over time, eliminating the need for long-term implant presence and potentially reducing the risk of infection or graft-related complications.
3D Printing and Patient-Specific Grafts: 3D printing technology enables the creation of patient-specific grafts tailored to individual anatomical requirements. This customization improves the accuracy of graft placement and ensures optimal fit and functionality. Patient-specific grafts can be designed to match complex anatomies, making them particularly useful in treating aortic aneurysms with challenging geometries.
Advanced Imaging Techniques: High-resolution imaging techniques such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA) play a crucial role in the diagnosis, planning, and post-operative evaluation of aortic and vascular graft procedures. These imaging modalities provide detailed visualization of the vasculature, aiding in precise graft sizing, placement, and surveillance.
Robotic-Assisted Surgery: Robotic-assisted surgical systems offer enhanced precision and dexterity to surgeons performing aortic and vascular graft procedures. These systems allow for smaller incisions, improved visualization, and greater maneuverability of surgical instruments. Robotic-assisted surgery can contribute to reduced trauma, faster recovery, and improved patient outcomes.
Nanotechnology: Nanotechnology has the potential to revolutionize aortic and vascular graft procedures. Nanomaterials, such as carbon nanotubes and nanofibers, can be incorporated into grafts to enhance their mechanical properties, promote cellular adhesion, and provide controlled drug release for targeted therapies. Nanotechnology-based approaches may lead to improved graft durability, reduced complications, and enhanced tissue regeneration.
For more insights on the North America Aortic and Vascular Graft Procedures market category analysis, download a free report sample
These emerging technologies and innovations in the North America Aortic and Vascular Graft Procedures market are driving advancements in the field, offering new treatment options, improving patient outcomes, and shaping the future of vascular surgery. Continued research and development in these areas hold the potential to further enhance the safety, efficacy, and long-term success of aortic and vascular graft procedures.
0 notes
anyawinget · 1 year ago
Text
Vascular Grafts Market Size, Status and Growth Outlook 2022-2030
“The market crossed the US$ 3.49 billion mark in 2022 and is expected to hit US$ 6.41 billion by 2030, recording a CAGR of 7.92% during the forecast period.”
The report includes an executive summary, economic outlook, and overview sections which provide a consistent analysis of the Vascular Grafts Market. Additionally, the report in the Market overview section outlines PLC analysis and PESTLE analysis to provide a thorough analysis of the market. The overview section details Porter’s five forces analysis which helps to reveal a possible scenario of the market by disclosing a competitive scenario with respect to the Vascular Grafts Market.
To Get a Sample Copy of the Report, Click Here:
https://www.businessmarketinsights.com/sample/BMIRE00026877
The Vascular Grafts market following is the manufacturer’s cover-
Medtronic plc
Getinge AB
LeMaitre Vascular Inc
WL Gore and Assocaites, Inc
Cook Medical
CR Bard
Terumo Corporation
Shanghai Suokang Medical Implants Co. Ltd.
The leading players of the Vascular Grafts industry, their market share, product portfolio, and company profiles are covered in this report. Key market players are analyzed on the basis of production volume, gross margin, market value, and price structure. The competitive market scenario among Vascular Grafts players will help the industry aspirants in planning their strategies. The statistics presented in this report are an accurate and helpful guide to shaping your business growth.
Vascular Grafts Market Split by Product Type and Applications:
This report segments the Vascular Grafts Market on the basis of Types are:
Hemodialysis Access Grafts
Endovascular Stents Grafts
Peripheral Vascular Graft
On the basis of Application, the Vascular Grafts Market is segmented into:
Cardia Aneurysm
Kidney Failure
Vascular Occlusion
Coronary Heart Disease
This analysis report also presents practical and practical case studies to help you get a clearer understanding of the subject. This analysis report has been prepared through industry analysis techniques and presented in a professional manner by including effective information graphics whenever necessary. It helps ensure business stability and rapid development to achieve notable remarks within the Vascular Grafts market.
Table of Content for Vascular Grafts Market Research Report:
Chapter 1: Industry Overview
Chapter 2: Vascular Grafts Market International and Regional Market Analysis
Chapter 3: Environment Analysis of Market.
Chapter 4: Analysis of Revenue by Classifications.
Chapter 5: Analysis of Revenue by Regions and Applications.
Chapter 6: Analysis of Vascular Grafts Market Revenue Market Status.
Chapter 7: Analysis of Industry Key Manufacturers
Chapter 8: Sales Price and Gross Margin Analysis of Market.
Chapter 9: ……………………. Continue to TOC
Finally, Vascular Grafts Market report is the believable source for gaining the Market research that will exponentially accelerate your business. The report provides locales, economic conditions, item values, benefits, limits, creations, supplies, requests, market development rates, and numbers, etc. Vascular Grafts industry report announces additional new task SWOT examination, and speculation achievement investigation and venture return investigation.
Click Here to Buy Now:
https://www.businessmarketinsights.com/buy/single/BMIRE00026877
Note: This report may be customized to suit your requirements. Get in touch with our sales team so you can get a report tailored to your needs.
About Us:
Business Market Insights is a market research platform that provides subscription services for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact Us:
If you have any questions about this report or would like further information, please contact us:
Contact person: Sameer Joshi
Phone: +16467917070
Web URL: https://www.businessmarketinsights.com
0 notes
the-rachana · 2 years ago
Text
Aortic Aneurysm Market Growth Elements, Recent Developments, and Key Players Strategy till 2031
The report extensively examines the global Aortic Aneurysm market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Aortic Aneurysm. For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market for Aortic Aneurysm. We assist you with full and extensive research on the global Aortic Aneurysm Market using qualitative and quantitative analysis. Additionally, we concentrated on SWOT, PESTLE, and Porter's Five Forces assessments of the worldwide market for Aortic Aneurysm.
Get Sample Report With Graphs and Table @ https://www.growthplusreports.com/inquiry/request-sample/aortic-aneurysm-market/8565
Key Players Mentioned in the Global Aortic Aneurysm Market Research Report:
Medtronic plc
Gore Medical (W. L. Gore & Associates)
Endologix LLC
Cardinal Health Inc.
Terumo Corporation
Cook Medical Inc.
JOTEC (Cryolife Inc.)
MicroPort Scientific Corporation
Lombard Medical
Cardiatis S.A.
SEGMENTS
GLOBAL AORTIC ANEURYSM DEVICES MARKET - ANALYSIS & FORECAST, BY TYPE
Thoracic Aortic Aneurysm (TAA)
Abdominal Aortic Aneurysm (AAA)
GLOBAL AORTIC ANEURYSM MARKET - ANALYSIS & FORECAST, BY TREATMENT
Open Surgical Repair (OSR)
Endovascular Aneurysm Repair (EVAR)
GLOBAL AORTIC ANEURYSM MARKET - ANALYSIS & FORECAST, BY PRODUCTS
Stent Grafts
Catheters
GLOBAL AORTIC ANEURYSM MARKET - ANALYSIS & FORECAST, BY END USER
Hospitals
Ambulatory Surgery Centers
Clinic
Finding dominant companies in a specific Aortic Aneurysm industry is only one aspect of an analyst's role. To produce a thorough and comprehensive Aortic Aneurysm research study, analysts put out significant work, invest hours in research and analysis, compile unique information from market specialists, and draw on their own expertise and knowledge of the sector. One of a market research report's most crucial sections is the company profiling section since it offers players essential information they can use to improve their businesses or move them forward. In addition to identifying the leading companies in the global market for Aortic Aneurysm, this study also examines important facets of each company's operations and presents market growth estimates.
Aortic Aneurysm Market TOC: https://www.growthplusreports.com/report/toc/aortic-aneurysm-market/8565
Aortic Aneurysm Market: Regional analysis includes
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
For More Information or Query or Customization before buying, Visit at: https://www.growthplusreports.com/inquiry/customization/aortic-aneurysm-market/8565
Reasons to Buy This Report:
This file will help the peruses with appreciation the opposition interior the ventures and structures for the serious local weather to improve the feasible benefit. The document moreover facilities round the cutthroat scene of the market, and provides exhaustively the piece of the pie, industry positioning, contender organic system, market execution, new object advancement, recreation circumstance, development, and securing.
And so forth of the fundamental players, which assists the peruses with distinguishing the indispensable contenders and profoundly know the opposition instance of the market.
This record will help companions with greedy the global enterprise popularity and patterns of Aortic Aneurysm Administration Frameworks and offers them statistics on key market drivers, restrictions, difficulties, and open doors.
This document will aid companions with grasp contenders higher and collect experiences to reinforce their scenario in their organizations. The serious scene region contains the piece of the pie and rank (in extent and worth), contender environment, new object improvement, development, and obtaining.
This document stays refreshed with novel innovation mix, highlights, and the latest developments on the lookout.
This file assists companions with grasp the Coronavirus and Russia-Ukraine War Impact on the Aortic Aneurysm Administration Frameworks industry.
This record assists companions with obtaining bits of know-how into what locales to internationally target.
This file assists companions with obtaining experiences into the end-client perception regarding the reception of Aortic Aneurysm Administration Frameworks.
This document assists companions with distinguishing a component of the central members on the lookout and hold close their essential commitment.
Purchase this report now at 20% flat discount @ https://www.growthplusreports.com/checkout-8565
Visit our report store at - https://www.growthplusreports.com/report-store
Manan Sethi
Director, Market Insights
256 Chapman Road
STE 105-4, Newark,
New Castle - 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/
About US
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020."
0 notes
manideep8 · 2 years ago
Text
Abdominal Aortic Aneurysm Treatment Market Analysis - Forecast (2022 - 2027)
Abdominal Aortic Aneurysm Treatment Market size is estimated to reach $2.67 billion by 2027, growing at a CAGR of 5.82% during the forecast period 2022-2027. Abdominal aortic aneurysms are frequently discovered when a physical examination is performed for another reason or at the time of normal medical tests, like an ultrasound of the heart or abdomen. The objective of abdominal aortic aneurysm treatment is to avoid an aneurysm from breaking. Treatment may include cautious supervision or surgery. The kind of treatment adopted, relies on the size of the aortic aneurysm and how quickly it is developing. CT scan assesses the abdomen in more detail in patients with a particular abdominal grievance. It also evaluates the form of the aneurysm with more inclusive anatomical details of the mesenteric and iliac arteries, and also offers superior imaging of suprarenal aneurysms. Helical CT angiography can represent complexities that establish consequently to the treatment of abdominal aortic aneurysms with endovascular stent grafts. Long-term follow-up is needed to decide the complete spectrum and frequency of complexities that may establish after a favorable fix at the beginning. Conservation of spinal cord blood supply at the time of descending thoracic (TAA) and thoracoabdominal aortic aneurysm (TAAA) surgery is mandatory to avoid neurologic complexities. Investigations have been conducted to determine whether the preoperative and postoperative existence or absence of collateral arteries discovered by magnetic resonance angiography (MRA) is connected with spinal cord function at the time of the intraoperative exclusion of the segmental supply to the Adamkiewicz artery.
The increasing predominance of hypertension and hyperlipidemia is set to drive the Abdominal Aortic Aneurysm Treatment Market. The surging count of smokers with elderly male smokers requiring ultrasound screening along with pre-existing CT scans is set to propel the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027. This represents the Abdominal Aortic Aneurysm Treatment Industry Outlook.
Abdominal Aortic Aneurysm Treatment Market Report Coverage
The report: “Abdominal Aortic Aneurysm Treatment Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the  Abdominal Aortic Aneurysm Treatment Market.
By Treatment: Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR). By Product: Stent Graft, Catheter. By End Use: Hospital, Ambulatory Surgical Center, Others. By Geography: North America (U.S, Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).
Inquiry Before Buying : https://www.industryarc.com/reports/request-quote?id=15315
Key Takeaways
Geographically, North America Abdominal Aortic Aneurysm Treatment Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the increasing predominance of abdominal aortic aneurysm requiring abdominal and pelvic CT scans for deciding the size and extent of an aneurysm in the North American region.
Abdominal Aortic Aneurysm Treatment Market growth is being driven by the rising pervasiveness of abdominal aortic aneurysm globally requiring abdominal and pelvic CT scans for deciding the size and extent of an aneurysm owing to altered lifestyle and the expanding population of the elderly. However, the cost and availability of treatment are some of the major factors hampering the growth of the Abdominal Aortic Aneurysm Treatment Market.
Abdominal Aortic Aneurysm Treatment Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the   Abdominal Aortic Aneurysm Treatment Market report.
Request For Sample : https://www.industryarc.com/pdfdownload.php?id=15315
Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Treatment:
The Abdominal Aortic Aneurysm Treatment Market based on treatment can be further segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). The Endovascular Aneurysm Repair (EVAR) Segment held the largest market share in 2021. This growth is owing to the enhanced patient survival offered by the Endovascular Aneurysm Repair technique. Endovascular repair (EVAR) is the positioning of a stent graft (fabric-covered tube) into the aneurysm by way of a tiny hole in the blood vessels in the groin. CT scan has been performed consequent to Endovascular Repair of Abdominal Aortic Aneurysms. The heightened demand for minimally invasive processes owing to minimized hospital stays and patient trauma in conjunction with the soaring success rate provided by technologically progressive devices is further propelling the growth of the Endovascular Aneurysm Repair (EVAR) segment.
Furthermore, the Open Surgical Repair (OSR) segment is estimated to grow with the fastest CAGR of 6.5% during the forecast period 2022-2027 owing to the superior outcomes of open surgical repair (OSR) in comparison with endovascular aneurysm repair (EVAR) for infrarenal abdominal aortic aneurysm (IRAAA) as per results of a retrospective cohort investigation issued in the Journal Vascular Brasileiro and CT scan is recommended with or without contrast at 5-year intervals after open surgical repair for thoracic aortic disease.
Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Product:
The Abdominal Aortic Aneurysm Treatment Market based on the product can be further segmented into Stent Graft and Catheter. The Stent Graft Segment held the largest market share in 2021. This growth is owing to the surging application of stent-grafts in Abdominal Aortic Aneurysm Treatment. Nellix and Ovation stent-grafts are novel generation prostheses that use polymer technology to treat abdominal aortic aneurysms. CT scan can be performed postoperatively. The benefits of endovascular repair with stent-graft are further propelling the growth of this segment.
Furthermore, the Catheter segment is estimated to grow with the fastest CAGR of 6.7% during the forecast period 2022-2027 owing to the surging application of Catheter-based aortic aneurysm repair attributed to it being a safe and preferred option of treatment for numerous patients with aortic aneurysms and investigations being conducted for intra-arterial catheter=directed CT angiography for evaluation of endovascular aortic aneurysm repair.
Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Geography:
The Abdominal Aortic Aneurysm Treatment Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Abdominal Aortic Aneurysm Treatment Market) held the largest share with 39% of the overall market in 2021. The growth of this region is owing to the increasing predominance of abdominal aortic aneurysms in the region. The continued technological upgrades in the healthcare sector and the increasing predominance of cardiovascular diseases requiring CT scans are further driving the growth of the Abdominal Aortic Aneurysm Treatment Market in the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like expanding population of the elderly being more susceptible to incessant ailments requiring the application of CT scans in the Asia-Pacific region. The supportive government policies increased spending on healthcare, and proliferating modernization of medical infrastructure are further fuelling the progress of the   Abdominal Aortic Aneurysm Treatment Market in the Asia-Pacific region.
Abdominal Aortic Aneurysm Treatment Market Drivers
Surging Applications Of Abdominal Computed Tomography Angiography Are Projected To Drive The Growth Of   Abdominal Aortic Aneurysm Treatment Market:
Computed tomography angiography (CTA) transformed vascular imaging when vessels tinier than 1 mm in diameter were imaged with single-slice spiral CT. Other than its restricted invasiveness, the benefits of CT Angiography involve reduced cost and a possible minimization in the total volume of contrast material administered. With the quickest scanners presently accessible (16, 64, 256 slices), abdominal Computed Tomography Angiography may be carried out with as little as 50 mL of contrast material utilizing a saline flush. Typical abdominal uses of CTA involve assessment of the abdominal aorta, preoperative and postoperative evaluation for renal and liver transplantation, preoperative planning for hepatic segmentectomy and pancreatic surgery, mesenteric ischemia, and gastrointestinal (GI) hemorrhage. Additional uses involve cholecystectomy and splenectomy planning, and evaluation for renal arterial disease in the assessment of hypertension. The protocols for every use should be separately tailor-made to optimize imaging of the targeted vascular structures. CTA is typically the approved imaging modality for the assessment of the abdominal aorta in intense and non-emergent settings. The surging applications of abdominal computed tomography angiography are therefore fuelling the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027.
Heightened Applications Of Magnetic Resonance Angiography For The Treatment of Infrarenal Abdominal Aortic Aneurysms Are Expected To Boost The Demand Of Abdominal Aortic Aneurysm Treatment Market:
Magnetic resonance angiography (MRA) like Computed Tomography Angiography (CTA) has the advantage of being able to envision the complete aorta inclusive of its branch vessels. Dissimilar to CTA, it does not reveal the patient to radiation nor is iodinated contrast dye needed. This can be more attractive for patients with a contrast allergy or renal inadequacy. In patients with kidney ailments, non-gadolinium contrast agents prevail. Blood pool contrast agents, like ferumoxytol, may be utilized to improve MRA to offer good imaging quality. Additionally, typical investigations have discovered that non-contrast magnetic resonance imaging (MRI), when teamed with electrocardiographic- and cardiac-gated methods, has identical image quality in comparison with contrast-enhanced MRA images of the aorta. Time-resolved 3D phase-contrast MRI with three-directional velocity encoding, also termed as 4D flow MRI has currently emerged as an instrument to more thoroughly assess abdominal circulation. 4D flow MRI may permit for more precise aortic modeling in the future owing to its capability to concurrently assess vascular anatomy and hemodynamics. MRA is commensurate to CTA with respect to the precision of AAA assessments. The heightened applications of Magnetic Resonance Angiography for the treatment of Infrarenal Abdominal Aortic Aneurysms are driving the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027.
Abdominal Aortic Aneurysm Treatment Market Challenges
Handling Of The Ruptured Abdominal Aortic Aneurysm By Paramedics Poses Challenges To The Growth Of The Abdominal Aortic Aneurysm Treatment Market:
The ruptured abdominal aortic aneurysm is a time-critical medical emergency needing timely surgical intervention to provide any opportunity of survival. Even when identified early, 90% of patients will endure an out-of-hospital cardiac arrest prior to landing at the emergency department and of those who arrive at the theatre, only 40% will survive. The ruptured AAA needs urgent surgical intervention. These kinds of patients cannot be stabilized in the prehospital environment and endeavors to do so will be pointless and are likely to jeopardize patient care. The paramedic practitioners handling of the ruptured AAA must involve, and sometimes be restricted to, accelerated identification and practical transport to a hospital with competence in handling vascular emergencies. Intravascular access must not defer transport to a suitable receiving facility. Prehospital interventions like fluid administration can minimize the occurrence of post-operative complexities like acute renal failure. However, this should not be utilized to legitimize numerous cannulation efforts on the scene. The establishment of a fast-track pathway for direct admission to theatre could possibly save lives. Further research and the establishment of such a pathway should include all members of the multi-disciplinary team. These issues are hampering the growth of the Abdominal Aortic Aneurysm Treatment Market.
Buy Now : https://www.industryarc.com/purchasereport.php?id=15315
Abdominal Aortic Aneurysm Treatment Market - Landscape:
Product launches, mergers and acquisitions, joint ventures, and R&D Activities are key strategies adopted by players in the   Abdominal Aortic Aneurysm Treatment Market. Key companies of this market are:
Novartis Pharmaceuticals
Merck
Cook Medical Inc.
Endologix Inc.
W.L.Gore & Associates
Medtronic Plc.
Cardinal Health Inc.
Lombard Medical, Inc.
Terumo Aortic
Cardiatis S.A.
Recent Developments
In April 2021, Cardinal Health introduced Outcomes™, a digital ecosystem linking pharmacists, payers, and pharmaceutical firms to diminish the challenges of medicine non-adherence. Outcomes convey digital health solutions for personalized medication therapy administration, digital patient engagement, and tele pharmacy, through its Connect™ platform. Therefore, these three customer groups can enhance patient adherence to medicine, fuel superior health outcomes for patients, and reduce the cost of care.
In July 2020, Novartis declared a novel initiative to assist patients in low-income and lower-middle-income countries (LIC; LMIC) access economical medications to treat the principal symptoms of COVID-19 – a crucial requirement in the absence of a vaccine or curative treatment. Inflammation and respiratory issues connected with COVID-19 may bring about serious medical complexities and may result in demise in certain people, establishing an enormous burden on delicate healthcare systems. The Novartis COVID-19 portfolio involves 15 medications from its Sandoz division for gastrointestinal sickness, intense respiratory symptoms, pneumonia, and septic shock.
In March 2020, Endologix® Inc. declared that it has accepted an endorsement from the U.S. Food and Drug Administration (FDA) for the Alto™ Abdominal Stent Graft System (Alto). The firm accepted endorsement based on its supervisory compliance that involves the ELEVATE Investigational Device Exemption (IDE) clinical investigation. Agreeable to the terms of endorsement, the earliest 100 patients consequent to commercial introduction will be involved in a post-approval imaging study to decide constancy in instrument choice between Endologix’s internal imaging services and those of the implanting physicians.
Related Reports-
Endovascular Abdominal Aortic Aneurysm Repair Devices Market
Report Code: HCR 46793
Aortic Aneurysm Market
Report Code: HCR 81184
For more Lifescience and Healthcare related reports, please
click here
0 notes
Text
Branched Stent Grafts Market: Key Players to Gain Competitive Advantage
The global branched stent-grafts market expanded at a CAGR of 8.0%. between 2021 to 2028. The market has been ever-growing for the past few decades, the reason being the increasing number of coronary heart diseases. Further, the rising geriatric population will also drive the market over the forecast period.
ResearchMoz report delivers an in-depth analysis of the global stent grafts interface marketplace, including its size, key drivers for growth, major opportunities and challenges it faces along with the regional segments that will experience significant expansion over time.
Polymer-Based Technology to Drive the Branched Stent Grafts Market
Recently, polymer-based technologies have been recommended as an alternative to fix abdominal aortic aneurysms (AAA). There are two categories under this technology- one is Endovascular Aneurysm Sealing (EVAS), which uses polymer filled end bags and Nellix Stent Grafts. The second, EVAR, uses a thin neoprene-based neck sealing device that’s also called the Ovation stent graft. EVAS was not successful despite being in use for some time now but EVAR has established itself as safe and effective; leading to the expansion of the global branched stents market.
Growing Vascular Surgeries Boost Demand
The growing number of vascular surgeries are driving the global branched stent grafts market and will continue during the forecast period. This is primarily due to the growing geriatric population across the globe and growing cases of coronary heart diseases.
However, the poor durability of metallic grafts will impede the growth during the forecast period.
Nonetheless, the rising demand for biocompatible stents will allow the market to grow exponentially in the coming years.
The players in the global branched stent-grafts market include-
Abbott
Cook Medical
Eucatech AG
Merit Medical Systems
Endocor GmbH
Boston Scientific Corp.
Terumo Corp.
Medtronic
Biotronik
Alvimedica
Cardinal Health (Cordis)
Read More: https://www.beetribune.com/branched-stent-grafts-market-survey-report/
Key takeaways
ReseachMoz shares detailed insights on the branched stent grafts market, which will help the stakeholders to be informed and take thoughtful decisions to thrive in this space. Some of the key takeaways from the report.
The global branched stent grafts market will exhibit growth at 8.0% CAGR between 2021 to 2028.
The increasing prevalence of coronary artery diseases and the rising number of geriatric populations are driving this market.
Asia-Pacific holds a promising future as well for branched stent grafts due to its high incidence rates of coronary heart diseases. While North America will dominate the global branched stent market in the coming years.
Regional Outlook
 North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Greece
The Netherlands
Asia Pacific
Japan
China
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Download Report PDF: Branched Stent Grafts Market
0 notes
crediblemarketblogs · 2 years ago
Link
0 notes
jainm24 · 2 years ago
Text
Thoracic Stent Graft Market  Share, Industry Growth, Trend, Key Companies by 2028
The Global thoracic aortic stent-graft complications Market report published by Reports and Data is a concise summary on the thoracic aortic stent-graft complications industry and offers deep insights into the industry’s core structure and mechanism. The report digs into the key segments and sub-segments of the industry and offers a thorough study of the industry’s leading regional markets, competitive scenario, product and application segments, technology landscape, sales & distribution networks, and key industry statistics. Market insights included in the report have been compiled through extensive research, detailed market surveys, and expert interviews.
Key market dynamics illustrated in the report include market share, market size, revenue growth drivers, restraints, opportunities, threats, challenges, emerging market trends, product innovations, and industry revenue growth rate. Other imperative factors highlighted in the report are volatility in demand and supply graphs, production & consumption patterns, paradigm shifts in consumer preferences, import/export analysis, and a multitude of macro-economic and micro-economic growth indicators. Going ahead, the report elaborates on the highly competitive environment of the thoracic aortic stent-graft complications industry and discusses the strategic initiatives undertaken by each market player, including partnerships & collaborations, mergers & acquisitions, joint ventures, government & corporate deals, and new product launches.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4474
Some Key Factors Contributing to the Global Pharma & Healthcare Market Growth
Unprecedented revenue growth of the global pharma & healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health & wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in R&D activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.
Top Players in the Global thoracic aortic stent-graft complications Market:
Abbott Laboratories
Lombard Medical
Cordis Corporation
Terumo Corporation
Boston Scientific
MicroPort Scientific Corporation
Medtronic
Biosensors
Lifetech Scientific
Medtronic Plc
Evasc Medical Systems Corp.
Endologix
L.Gore & Associates, Inc.
TriVascular, Inc.
The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma & healthcare industry revenue growth over the recent past.  
To know more about the report @ https://www.reportsanddata.com/report-detail/thoracic-stent-graft-market
thoracic aortic stent-graft complications Market Segmentation:
Product Type Outlook (Revenue, USD Billion; 2018-2028)
Hemodialysis Access Graft
Endovascular Stent Graft
Peripheral vascular
Others
Application Outlook (Revenue, USD Billion; 2018-2028)
Cardiovascular Diseases
Cardiac Aneurysm
Kidney Failure
Others
Global thoracic aortic stent-graft complications Market Report: Regional Segmentation
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4474
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
0 notes
pranalipawarshinde · 2 years ago
Text
Scope for Vascular Graft Market 2016-2024
Vascular Graft Market:Overview
The demand within the global market for vascular graft has been rising on account of advancements in the field of cardiology, finds Transparency Market Research (TMR).The market vendors in the global market for vascular graft have been making ardent efforts to ensure a regular inflow of revenues in their kitty.
The competitive dynamics of the global vascular graft have intensified in the past few years. In other words, the vendors operating in the global vascular graft market have locked horns with themselves, and have earned key reward points. There is also a high possibility of new strategies and business plans being introduced by key vendors. 
Report Overview:
https://www.transparencymarketresearch.com/vascular-graft-market.html
The market vendors with a large consumer base in the global vascular graft market have been overpowering the ability of smaller vendors to sustain in the market. Since vascular grafts need to be of improved quality, the larger vendors have capitalised on manufacturing effective products. The smaller market vendors are expected to struggle to stay relevant in an ever-changing healthcare industry.It is also expected that the global market for vascular graft would become less fragmented in the forthcoming years. Some of the key vendors in the global vascular graft market are C.R. Bard, Inc., Cook Medical, Inc., and MAQUET Holding B.V. & Co. KG (Getinge Group). Transparency Market Research (TMR) finds that the global market for vascular graft would expand at a steady CAGR of 5.0% over the period ranging 2016-2024. Furthermore, the cumulative value of the global vascular graft market was US$2.15 bn in 2015, and is expected to touch a figure of US$3.29 bn by 2024-end. The regional segmentation of the market for vascular graft is led by North America in terms revenue. Furthermore, on the basis of product, peripheral vascular stents have gained popularity in recent times. 
Request A Sample:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11096
Rise in the Incidence of Cardiovascular Diseases to Push Market Growth 
The use of vascular grafts spans across multiple domains within healthcare, especially cardiology. These grafts help in redirecting the flow of blood inside the arteries, and this factor has led to their widespread popularity.
Furthermore, the presence of a seamless cardiology sector has also played an underhanded role in the growth of the global market for vascular graft in recent times. The treatment of coronary artery disease also depends on proper execution of vascular graft. Hence, there is no contention about the assertion that the global vascular graft market would expand at a boisterous pace in the years to come. 
 Investments in Healthcare to Propel Demand 
The demand within the global market for vascular graft has risen alongside advancements in the field of healthcare. Several healthcare entities and external organisations have made voluminous investments towards better vascular care.For this reason, the global market for vascular graft is expected to become a haven of lucrative opportunities in the years to come. Moreover, the treatment of vascular occlusion, aneurysm, and renal failure is also done with the help of vascular graft market. This factor has also created commendable opportunities for growth within the global market for vascular graft. 
Request for covid19 Impact Analysis:
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=11096
The review is based on TMR’s report titled, “Vascular Graft Market (Product - Endovascular Stent Graft, Peripheral Vascular Graft, Hemodialysis Access Graft, and Bypass Graft; End User - Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Cardiac Catheterization Laboratories; Source - Synthetic, Biosynthetic and Biological; Application - Coronary Artery Disease, Aneurysm, Vascular Occlusion, and Renal Failure) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024”. 
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/skin-care-devices-market-to-advance-at-cagr-of-9-9-during-20212028--says-tmr-301510121.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive combination of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Contact 
90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: https://www.transparencymarketresearch.com
0 notes
metiresearchinfo · 3 years ago
Text
Peripheral Vascular Devices Market : Meticulous Research® Reveals Why this Market is Growing at a CAGR of 6.9% to Reach 12.02 Billion by 2028
In its latest publication on the peripheral vascular devices market, Meticulous Research® analyses that the market is expected to grow at a CAGR of 6.9% from 2021 to 2028 to reach $12.02 billion. The increasing prevalence of peripheral vascular diseases associated with obesity, diabetes, and hypertension; growing geriatric population; increasing demand for minimally invasive treatment options; and increasing prevalence of disease-causing lifestyles are the major factors driving the growth of this market.
To provide efficient analysis, Meticulous Research has segmented this market based on type [angioplasty balloons (old/normal balloons, drug-eluting balloons, cutting & scoring balloons);  angioplasty stents (drug-eluting stents, bare-metal stents (expandable balloon stents, self-expandable stents)); catheters (angiography catheters, guiding catheters, IVUS/OCT catheters); endovascular aneurysm repair stent grafts (abdominal aortic aneurysm stent-grafts, thoracic aortic aneurysm stent grafts); inferior vena cava filters (retrievable filters, permanent filters); plaque modification devices (atherectomy devices, thrombectomy devices); hemodynamic flow alteration devices (embolic protection devices, chronic total occlusion devices); and other devices] and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).
Download Sample Report Now : https://www.meticulousresearch.com/download-sample-report/cp_id=5180
Based on type, the peripheral vascular devices market is segmented into angioplasty stents, angioplasty balloons, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other types. In 2020, the angioplasty stents segment accounted for the largest share of the peripheral vascular devices market. Factors driving the growth of this segment include reduced restenosis rate associated with these products and their benefits, such as smaller incisions, faster recovery time, and lower risk of complications.
Based on geography, this research report analyzes and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. In 2020, North America dominated the peripheral vascular devices market, followed by Europe and Asia-Pacific. Factors such as the increasing prevalence of peripheral artery diseases, aortic aneurysms, and pulmonary embolisms; increasing number of obese & diabetic population; and the presence of key players are driving the growth of this regional segment.
Speak to our Analysts to Understand the In Detail Impact of COVID-19 on Your Business:  https://www.meticulousresearch.com/speak-to-analyst/cp_id=5180
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, market share analysis, and geographical presence on some of the key players in this market, including Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), BIOTRONIK SE & Co. KG (Germany), Blue Sail Medical Co., Ltd. (China), Boston Scientific Corporation (U.S.), Cardinal Health, Inc. (U.S.), Cook Group (U.S.), Edwards Lifesciences Corporation (U.S.), iVascular (Spain), Koninklijke Philips N.V. (Netherlands), Medtronic Public Limited Company (Ireland), Nipro Corporation (Japan), TE Connectivity LTD. (Switzerland), and Terumo Corporation (Japan).
You can buy report here : https://www.meticulousresearch.com/Checkout/12322365
Contact: Mr. Khushal Bombe Meticulous Market Research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- [email protected] Visit Our Website: https://www.meticulousresearch.com/ Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
0 notes
leftcomputerpost · 3 years ago
Text
Aortic Stents Grafts Market will reach a valuation around 2.8 billion by 2028
Future Market Insights delivers key insights and presents a revised forecast of the global aortic stent grafts market for a 10-year period from 2018 to 2028 in the report titled “Aortic Stent Grafts Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028.” The revision in the market size and volume forecasts has been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of the key market participants. In terms of revenue, the global aortic stent grafts market is projected to expand at a 7.6% CAGR over the forecast period of 2018–2028.
North America is expected to contribute a high revenue share in the global aortic stent grafts market over the forecast period. North America is witnessing a large demand for aortic stent grafts due to high adoption of endovascular repair surgeries, which is expected to boost the growth of the aortic stent grafts market.
The global market is segmented based on product type, end users and region. Based on the product type the market is segmented into abdominal aortic stent graft and thoracic aortic stent grafts. Abdominal aortic stent graft product type segment is expected to represent high revenue share in the global aortic stent grafts market. The thoracic aortic stent graft segment is expected to gain significant share in the forecast period due to increasing focus of the manufacturers on product launch for TEVAR procedures. Based on end users, the market is segmented into the hospitals and ambulatory surgical centers/outpatient surgical centers. Among both the end users, the hospitals is expected to be the leading segment the market.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-865
New product launches with improved stent graft designs are expected to provide enormous opportunities for the growth of the aortic stent grafts market and fulfil the demand from surgeons to overcome complications during surgeries. Increasing government initiatives to reduce the burden of abdominal aortic aneurysm, favourable recommendation and regulatory approvals, mergers, and acquisitions among manufacturers are the key market trends, which are expected to boost the growth of aortic stent grafts market.
Increasing prevalence of aortic aneurysm among the older population, favourable reimbursement policies, adoption of new minimally invasive technologies are the major factors expected to impel the growth of the aortic stents grafts market. Increasing number of government screening programs for people over 65 age has provided huge growth opportunities for the manufacturers operating in the aortic stent grafts market. However, product recalls and lack of skilled healthcare professionals are factors hindering the growth of the aortic stent grafts market.
The market for aortic stent grafts market is consolidated with large number of major players operating in the global market. Examples of some of the key players identified in global aortic stent grafts market are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, INC., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, Cryolife Inc., and Lombard Medical Inc.
Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-865
About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: [email protected] For Media Enquiries: [email protected] Website: https://www.futuremarketinsights.com
0 notes
manideep8 · 2 years ago
Text
Aortic Intervention Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2022 - 2027
Aortic Intervention Market size is estimated to reach $3.4 billion by 2027, growing at a CAGR of 6.7% during the forecast period 2022-2027. Aortic intervention includes mending of aortic valve walls when an aneurysm happens. There has been immense progress in the endovascular treatment of aortic pathologies. Intra-renal abdominal aortic aneurysms can be treated by endovascular graft in most cases and endovascular aortic repair has acquired expansive acceptance all through the world. The abdominal aorta is the biggest artery in the abdominal cavity. As a portion of the aorta, it is a direct extension of the descending aorta (of the thorax). The thoracic aorta starts at the heart, at the level of the aortic valves. The thoracic aorta evolves into the abdominal aorta at the diaphragm, just bordering the celiac artery origin, normally at the T12 vertebral body.
Report Coverage
The report : “Aortic Intervention Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Aortic Intervention Market.
By Device Type : Abdominal Aortic Stent Grafts. Thoracic Aortic Stent Grafts, Fenestrated Aortic Stent Grafts, Others. By End User : Hospitals, Clinics, Others. By Geography : North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).
0 notes
Text
Branched Stent Grafts Market to Reflect Impressive Growth Rate
The global branched stent-grafts market expanded at a CAGR of 8.0%. between 2021 to 2028. The market has been ever-growing for the past few decades, the reason being the increasing number of coronary heart diseases. Further, the rising geriatric population will also drive the market over the forecast period.
ResearchMoz report delivers an in-depth analysis of the global stent grafts interface marketplace, including its size, key drivers for growth, major opportunities and challenges it faces along with the regional segments that will experience significant expansion over time.
Polymer-Based Technology to Drive the Branched Stent Grafts Market
Recently, polymer-based technologies have been recommended as an alternative to fix abdominal aortic aneurysms (AAA). There are two categories under this technology- one is Endovascular Aneurysm Sealing (EVAS), which uses polymer filled end bags and Nellix Stent Grafts. The second, EVAR, uses a thin neoprene-based neck sealing device that’s also called the Ovation stent graft. EVAS was not successful despite being in use for some time now but EVAR has established itself as safe and effective; leading to the expansion of the global branched stents market.
Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/request-free-sample/?reportid=1453
Growing Vascular Surgeries Boost Demand
The growing number of vascular surgeries are driving the global branched stent grafts market and will continue during the forecast period. This is primarily due to the growing geriatric population across the globe and growing cases of coronary heart diseases.
However, the poor durability of metallic grafts will impede the growth during the forecast period.
Nonetheless, the rising demand for biocompatible stents will allow the market to grow exponentially in the coming years.
The players in the global branched stent-grafts market include-
Abbott
Cook Medical
Eucatech AG
Merit Medical Systems
Endocor GmbH
Boston Scientific Corp.
Terumo Corp.
Medtronic
Biotronik
Alvimedica
Cardinal Health (Cordis)
Key takeaways
ReseachMoz shares detailed insights on the branched stent grafts market, which will help the stakeholders to be informed and take thoughtful decisions to thrive in this space. Some of the key takeaways from the report.
The global branched stent grafts market will exhibit growth at 8.0% CAGR between 2021 to 2028.
The increasing prevalence of coronary artery diseases and the rising number of geriatric populations are driving this market.
Asia-Pacific holds a promising future as well for branched stent grafts due to its high incidence rates of coronary heart diseases. While North America will dominate the global branched stent market in the coming years.
Inquire More About This Report: https://www.researchmoz.us/enquiry-before-buying/?reportid=1453
Regional Outlook
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Greece
The Netherlands
Asia Pacific
Japan
China
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Download Report PDF: Branched Stent Grafts Market
Have a Look at Other Research Reports:
Aerospace Lubricant Market - https://www.beetribune.com/aerospace-lubricant-market-forecast/
Plant-based Milk Market - https://www.beetribune.com/plant-based-milk-market-revenue/
Adhesive Equipment Market - https://www.beetribune.com/adhesive-equipment-market-growth/
Adaptive Optics Market - https://www.beetribune.com/the-global-adaptive-optics-market-forecast/
Active Electronic Components Market - https://www.beetribune.com/the-global-active-electronic-components-market-research-report/
Acoustic Diaphragm Market - https://www.beetribune.com/acoustic-diaphragm-market-outlook/
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz Abhishek Budholiya Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: [email protected] Follow us on LinkedIn: https://www.linkedin.com/company/researchmoz Follow us on Twitter: https://twitter.com/researchmoz Media Release: https://www.researchmoz.us/pressrelease
0 notes